Fermentates of barley polysaccharides by Bifidobacterium longum suppress colorectal cancer associated with modulation of Wnt/β-catenin signaling and metabolic profiles
Year: 2026
Type: article
Abstract: Colorectal cancer (CRC) remains a major global health burden. This study evaluated the anti-CRC potential of barley polysaccharide fermentation products by Bifidobacterium longum PXC-Bi01 (designated BLF). BLF inhibited HT-29 colon cancer cell proliferation through G1-phase cell cycle arrest and dose-dependent apoptosis. In an AOM/DSS-induced CRC mouse model, BLF intervention ameliorated colonic pathology, reduced tumor burden, and normalized serum myeloperoxidase (MPO) activity. Mechanistically, BLF intervention was associated with suppression of Wnt/β-catenin signaling, characterized by downregulation of key oncogenic drivers (Wnt3a, β-catenin, and c-Myc) and upregulation of negative regulators (Axin1, Apc, and Gsk-3β). Metabolomic profiling of fermentation products and host serum tentatively annotated six candidate metabolites enriched by fermentation, including Dodecyl-β-D-maltoside and β-Thujaplicin. Their elevated relative abundances in serum correlated strongly with improved pathological indices and normalized Wnt pathway markers. Proof-of-concept experiments showed that Dodecyl-β-D-maltoside exerted concentration-dependent cytotoxicity against HT-29 cells while sparing normal colonic epithelial cells and significantly attenuated β-catenin and c-Myc protein expression. These findings suggest that BLF may exert anti-CRC effects associated with fermentation-derived metabolites and modulation of the Wnt/β-catenin pathway, pointing to the biological potential of fermentation-derived metabolites in experimental CRC models.
Source: npj Science of Food
Institution: Jinan University
Language: English
Topic: Gut microbiota and health
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $2,790
OpenAlex ID: W7237365271
FWCI:
Cites:
Cited by:
Related to:
